Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
19.28
+0.23 (1.21%)
At close: Dec 5, 2025, 4:00 PM EST
19.07
-0.21 (-1.09%)
After-hours: Dec 5, 2025, 6:19 PM EST

Sabra Health Care REIT Statistics

Total Valuation

SBRA has a market cap or net worth of $4.81 billion. The enterprise value is $7.20 billion.

Market Cap 4.81B
Enterprise Value 7.20B

Important Dates

The last earnings date was Wednesday, November 5, 2025, after market close.

Earnings Date Nov 5, 2025
Ex-Dividend Date Nov 17, 2025

Share Statistics

SBRA has 249.35 million shares outstanding. The number of shares has increased by 2.41% in one year.

Current Share Class 249.35M
Shares Outstanding 249.35M
Shares Change (YoY) +2.41%
Shares Change (QoQ) +1.09%
Owned by Insiders (%) 1.53%
Owned by Institutions (%) 95.13%
Float 245.45M

Valuation Ratios

The trailing PE ratio is 26.47 and the forward PE ratio is 26.01. SBRA's PEG ratio is 2.41.

Price/FFO Ratio 13.05
Price/AFFO Ratio n/a
PE Ratio 26.47
Forward PE 26.01
PS Ratio 6.14
Forward PS 6.13
PB Ratio 1.70
P/TBV Ratio 1.74
P/FCF Ratio n/a
P/OCF Ratio 14.09
PEG Ratio 2.41
Financial Ratio History

Enterprise Valuation

EV / Earnings 41.15
EV / Sales 9.64
EV / EBITDA 15.81
EV / EBIT 25.49
EV / FCF n/a

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.92.

Current Ratio 2.99
Quick Ratio 2.62
Debt / Equity 0.92
Debt / EBITDA 5.70
Debt / FCF n/a
Interest Coverage 2.54

Financial Efficiency

Return on equity (ROE) is 6.28% and return on invested capital (ROIC) is 3.32%.

Return on Equity (ROE) 6.28%
Return on Assets (ROA) 3.23%
Return on Invested Capital (ROIC) 3.32%
Return on Capital Employed (ROCE) 5.19%
Revenue Per Employee $14.94M
Profits Per Employee $3.50M
Employee Count 50
Asset Turnover 0.14
Inventory Turnover n/a

Taxes

In the past 12 months, SBRA has paid $1.73 million in taxes.

Income Tax 1.73M
Effective Tax Rate 0.98%

Stock Price Statistics

The stock price has increased by +4.61% in the last 52 weeks. The beta is 0.66, so SBRA's price volatility has been lower than the market average.

Beta (5Y) 0.66
52-Week Price Change +4.61%
50-Day Moving Average 18.42
200-Day Moving Average 18.09
Relative Strength Index (RSI) 58.72
Average Volume (20 Days) 3,033,067

Short Selling Information

The latest short interest is 19.47 million, so 7.81% of the outstanding shares have been sold short.

Short Interest 19.47M
Short Previous Month 18.88M
Short % of Shares Out 7.81%
Short % of Float 7.93%
Short Ratio (days to cover) 6.47

Income Statement

In the last 12 months, SBRA had revenue of $747.06 million and earned $175.08 million in profits. Earnings per share was $0.73.

Revenue 747.06M
Gross Profit 497.79M
Operating Income 282.60M
Pretax Income 176.78M
Net Income 175.08M
EBITDA 455.63M
EBIT 282.60M
Earnings Per Share (EPS) $0.73
Full Income Statement

Balance Sheet

The company has $204.42 million in cash and $2.60 billion in debt, giving a net cash position of -$2.40 billion or -$9.61 per share.

Cash & Cash Equivalents 204.42M
Total Debt 2.60B
Net Cash -2.40B
Net Cash Per Share -$9.61
Equity (Book Value) 2.83B
Book Value Per Share 11.33
Working Capital 233.57M
Full Balance Sheet

Cash Flow

Operating Cash Flow 341.15M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 66.63%, with operating and profit margins of 37.83% and 23.44%.

Gross Margin 66.63%
Operating Margin 37.83%
Pretax Margin 23.66%
Profit Margin 23.44%
EBITDA Margin 60.99%
EBIT Margin 37.83%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of $1.20, which amounts to a dividend yield of 6.22%.

Dividend Per Share $1.20
Dividend Yield 6.22%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 164.72%
Buyback Yield -2.41%
Shareholder Yield 3.81%
Earnings Yield 3.64%
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SBRA is $20.56, which is 6.64% higher than the current price. The consensus rating is "Hold".

Price Target $20.56
Price Target Difference 6.64%
Analyst Consensus Hold
Analyst Count 9
Revenue Growth Forecast (5Y) 9.32%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 6